Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease

Author:

Fajgenbaum David C.1ORCID,Wu David2,Goodman Aaron3,Wong Raymond4ORCID,Chadburn Amy5,Nasta Sunita6,Srkalovic Gordan7,Mukherjee Sudipto8,Leitch Heather9,Jayanthan Raj10,Ferrero Simone11ORCID,Sato Yasuharu12,Schey Steve13,Dispenzieri Angela14ORCID,Oksenhendler Eric15,Zinzani Pier Luigi16ORCID,Lechowicz Mary Jo17,Hoffmann Christian18,Pemmaraju Naveen19,Bagg Adam20,Fossa Alexander21,Lim Megan S.20,Rhee Frits22ORCID,

Affiliation:

1. Division of Translational Medicine and Human Genetics, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania

2. Department of Laboratory Medicine University of Washington Seattle Washington

3. Division of Blood and Marrow Transplantation UC San Diego Moores Cancer Center La Jolla California

4. Sir Y.K. Pao Centre for Cancer & Department of Medicine & Therapeutics Prince of Wales Hospital, The Chinese University of Hong Kong Sha Tin Hong Kong

5. Department of Pathology and Laboratory Medicine Weill Cornell Medical College New York New York USA

6. Division of Hematology/Oncology, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

7. Sparrow Cancer Center Edward W. Sparrow Hospital Association Lansing Michigan USA

8. Department of Hematology and Medical Oncology Cleveland Clinic Cleveland Ohio USA

9. Division of Hematology University of British Columbia Vancouver British Columbia Canada

10. Department of Pediatrics Montefiore Medical Center Bronx New York USA

11. Division of Hematology University of Torino Torino Italy

12. Department of Pathology Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Okayama Japan

13. Department of Haematological Medicine, Kings' College London University London UK

14. Division of Hematology Mayo Clinic Rochester Minnesota USA

15. Department of Clinical Immunology Hopital Saint‐Louis Paris France

16. Institute of Haematology University of Bologna Bologna Italy

17. Department of Hematology and Medical Oncology Emory University School of Medicine Atlanta Georgia

18. ICH Study Center GmbH & Co KG Hamburg Germany

19. Department of Leukemia MD Anderson Cancer Center Houston Texas

20. Department of Pathology & Laboratory Medicine, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania

21. Department of Oncology Oslo University Hospital – Norwegian Radium Hospital Oslo Norway

22. Myeloma Center University of Arkansas for Medical Sciences Little Rock Arkansas

Publisher

Wiley

Subject

Hematology

Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3